MetLife Investment Advisors »

Protalix Biotherapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $95k 44k 2.17
2023-06-30 $65k 32k 2.00

More positions owned by MetLife Investment Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A Cap Stk Cl (GOOGL)
Broadcom (AVGO)
Alphabet Inc Class C Cap Stk Cl (GOOG)
Meta Platforms Inc Class A Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Class B Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
State Street Spdr S&p Etf Trust Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Vanguard Short-term Bond Index Fun Short Trm (BSV)
Exxon Mobil Corporation (XOM)

View all positions for MetLife Investment Advisors

Top funds holding Protalix Biotherapeutics

BlackRock
MAK Capital One
Renaissance Technologies
State Street Corporation
Northern Trust
Geode Capital Management
Stratos Wealth Partners
Vanguard Portfolio Management
Prospera Financial Services
Opaleye Management
Morgan Stanley
Dimensional Fund Advisors
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Susquehanna International
UBS Group

View all funds holding Protalix Biotherapeutics